Dose-reduced Versus Standard Conditioning in MDS/sAML

Clinical trial NCT01203228 · TERMINATED

Trial details

NCT number: NCT01203228
Sponsor: European Society for Blood and Marrow Transplantation
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Myelodysplastic Syndromes Secondary Acute Myeloid Leukemia

Start date: 2004-05-01
Primary completion: 2015-01-01
Enrollment: 129

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.